Immunotherapies and immunomodulatory approaches in clinical trials - a mini review
The coronavirus disease (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has created havoc worldwide. Due to the non-availability of any vaccine or drugs against COVID-19, immunotherapies involving convalescent plasma, immunoglobulins, antibodies (monocl...
Saved in:
Main Authors: | Mohd. Iqbal Yatoo (Author), Zeenat Hamid (Author), Izhar Rather (Author), Qurat Ul Ain Nazir (Author), Riyaz Ahmed Bhat (Author), Abrar Ul Haq (Author), Suhail Nabi Magray (Author), Zulfqar Haq (Author), Ranjit Sah (Author), Ruchi Tiwari (Author), SenthilKumar Natesan (Author), Muhammad Bilal (Author), Harapan Harapan (Author), Kuldeep Dhama (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plant-based vaccines and antibodies to combat COVID-19: current status and prospects
by: Kuldeep Dhama, et al.
Published: (2020) -
Geriatric Population During the COVID-19 Pandemic: Problems, Considerations, Exigencies, and Beyond
by: Kuldeep Dhama, et al.
Published: (2020) -
Antivirals for COVID-19: A critical review
by: Andri Frediansyah, et al.
Published: (2021) -
COVID-19 - Recent advancements in identifying novel vaccine candidates and current status of upcoming SARS-CoV-2 vaccines
by: Mohd. Iqbal Yatoo, et al.
Published: (2020) -
Remdesivir and its antiviral activity against COVID-19: A systematic review
by: Andri Frediansyah, et al.
Published: (2021)